Fesoterodine fumarate
Fesoterodine Fumarate is a prescription medication available as extended-release oral tablets in 4mg and 8mg strengths. Manufactured by Amneal Pharmaceuticals LLC under application ANDA205002, it is a generic version for treating overactive bladder symptoms. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Fesoterodine Fumarate is a prescription medication available as extended-release oral tablets in 4mg and 8mg strengths. Manufactured by Amneal Pharmaceuticals LLC under application ANDA205002, it is a generic version for treating overactive bladder symptoms. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Fesoterodine fumarate", "mediaType": "text/html", "description": " Access the FDA dataset for Fesoterodine fumarate — ANDA 022030 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022030" } ] |
| identifier | ANDA022030 |
| issued | 2016-09-16 |
| keyword |
[ "drug-information", "drug-manufacturers", "health-care", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Fesoterodine fumarate |
